These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9761508)

  • 1. Hyperleptinaemia of end-stage renal disease is corrected by renal transplantation.
    Landt M; Brennan DC; Parvin CA; Flavin KS; Dagogo-Jack S; Coyne DW
    Nephrol Dial Transplant; 1998 Sep; 13(9):2271-5. PubMed ID: 9761508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased plasma leptin concentration in end-stage renal disease.
    Merabet E; Dagogo-Jack S; Coyne DW; Klein S; Santiago JV; Hmiel SP; Landt M
    J Clin Endocrinol Metab; 1997 Mar; 82(3):847-50. PubMed ID: 9062494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma leptin concentration in kidney transplant patients during the early post-transplant period.
    Kokot F; Adamczak M; Wiecek A
    Nephrol Dial Transplant; 1998 Sep; 13(9):2276-80. PubMed ID: 9761509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma immunoreactive leptin concentration in end-stage renal disease.
    Howard JK; Lord GM; Clutterbuck EJ; Ghatei MA; Pusey CD; Bloom SR
    Clin Sci (Lond); 1997 Aug; 93(2):119-26. PubMed ID: 9301426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma immunoreactive leptin and neuropeptide Y levels in kidney transplant patients.
    Kokot F; Adamczak M; Wiecedil;cek A; Spiechowicz U; Mesjasz J
    Am J Nephrol; 1999; 19(1):28-33. PubMed ID: 10085446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma adiponectin concentration before and after successful kidney transplantation.
    Chudek J; Adamczak M; Karkoszka H; Budziński G; Ignacy W; Funahashi T; Matsuzawa Y; Cierpka L; Kokot F; Wiecek A
    Transplant Proc; 2003 Sep; 35(6):2186-9. PubMed ID: 14529883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum concentrations of leptin in heart, liver and kidney transplant recipients.
    Kagan A; Haran N; Leschinsky L; Sarafian R; Aravot D; Dolberg J; Ben-Ary Z; Rapoport J
    Isr Med Assoc J; 2002 Mar; 4(3):213-7. PubMed ID: 11908268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of leptin and insulin-like growth factor I to nutritional status in hemodialyzed children.
    Besbas N; Ozaltin F; Coşkun T; Ozalp S; Saatçi U; Bakkaloğlu A; El Nahas AM
    Pediatr Nephrol; 2003 Dec; 18(12):1255-9. PubMed ID: 14586683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial natriuretic peptide in renal transplantation.
    Plum J; Scholtz W; Grabensee B
    Horm Res; 1996; 46(2):74-82. PubMed ID: 8871185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum leptin concentrations correlate to plasma insulin concentrations independent of body fat content in chronic renal failure.
    Stenvinkel P; Heimbürger O; Lönnqvist F
    Nephrol Dial Transplant; 1997 Jul; 12(7):1321-5. PubMed ID: 9249764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of renal transplantation on biomarkers of inflammation and oxidative stress in end-stage renal disease patients.
    Simmons EM; Langone A; Sezer MT; Vella JP; Recupero P; Morrow JD; Ikizler TA; Himmelfarb J
    Transplantation; 2005 Apr; 79(8):914-9. PubMed ID: 15849543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma leptin level and its relationship with body composition in hemodialysis patients.
    Nishizawa Y; Shoji T; Tanaka S; Yamashita M; Morita A; Emoto M; Tabata T; Inoue T; Morii H
    Am J Kidney Dis; 1998 Apr; 31(4):655-61. PubMed ID: 9531182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laparoscopic sleeve gastrectomy: gateway to kidney transplantation.
    Kienzl-Wagner K; Weissenbacher A; Gehwolf P; Wykypiel H; Öfner D; Schneeberger S
    Surg Obes Relat Dis; 2017 Jun; 13(6):909-915. PubMed ID: 28216112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leptin and adiponectin during the first week after kidney transplantation: biomarkers of graft dysfunction?
    Fonseca I; Oliveira JC; Santos J; Malheiro J; Martins LS; Almeida M; Dias L; Pedroso S; Lobato L; Henriques AC; Mendonça D
    Metabolism; 2015 Feb; 64(2):202-7. PubMed ID: 25458832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Hyperuricemia on Long-term Outcomes of Kidney Transplantation: Analysis of the FAVORIT Study.
    Kalil RS; Carpenter MA; Ivanova A; Gravens-Mueller L; John AA; Weir MR; Pesavento T; Bostom AG; Pfeffer MA; Hunsicker LG
    Am J Kidney Dis; 2017 Dec; 70(6):762-769. PubMed ID: 28801121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decrease of serum chemerin concentration in patients with end stage renal disease after successful kidney transplantation.
    Rutkowski P; Sledzinski T; Zielinska H; Lizakowski S; Goyke E; Szrok-Wojtkiewicz S; Swierczynski J; Rutkowski B
    Regul Pept; 2012 Jan; 173(1-3):55-9. PubMed ID: 21971116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma ghrelin levels in patients with end-stage renal disease.
    Jarkovská Z; Rosická M; Krsek M; Sulková S; Haluzík M; Justová V; Lacinová Z; Marek J
    Physiol Res; 2005; 54(4):403-8. PubMed ID: 15588149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum leptin, insulin resistance, and body fat after renal transplantation.
    Souza GC; Costa C; Scalco R; Gonçalves LF; Manfro RC
    J Ren Nutr; 2008 Nov; 18(6):479-88. PubMed ID: 18940650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recovery of OATP1B Activity after Living Kidney Transplantation in Patients with End-Stage Renal Disease.
    Suzuki Y; Ono H; Tanaka R; Sato F; Sato Y; Ohno K; Mimata H; Itoh H
    Pharm Res; 2019 Feb; 36(4):59. PubMed ID: 30809779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of renal transplantation on survival in end-stage renal disease patients with elevated body mass index.
    Glanton CW; Kao TC; Cruess D; Agodoa LY; Abbott KC
    Kidney Int; 2003 Feb; 63(2):647-53. PubMed ID: 12631130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.